The present invention relates to the field of tissue injury. More specifically the present invention provides pharmaceutical compositions useful for the treatment of tissue injury. In certain embodiments a pharmaceutical composition comprises (a) a stem cell mobilizer and (b) an immunosuppressive agent or non immunosuppressive FK binding protein ligand. The pharmaceutical compositions of the invention can be administered by a variety of routes and dosing regimens.
